These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16866907)

  • 21. [Role of apolipoprotein E in the molecular pathomechanism of Alzheimer disease].
    Michikawa M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2014 Feb; 34(1):5-9. PubMed ID: 25069266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer's disease.
    Posse de Chaves E
    Can J Physiol Pharmacol; 2012 Jun; 90(6):753-64. PubMed ID: 22626060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease.
    Martins IJ; Berger T; Sharman MJ; Verdile G; Fuller SJ; Martins RN
    J Neurochem; 2009 Dec; 111(6):1275-308. PubMed ID: 20050287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Apolipoprotein E4 and late-onset Alzheimer's disease].
    Tamaoka A
    Nihon Rinsho; 1994 Dec; 52(12):3257-65. PubMed ID: 7853720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk factors for Alzheimer's disease].
    Yanagisawa K
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1225-7. PubMed ID: 11464462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the cause of sporadic Alzheimer's disease.
    Zetterberg H; Mattsson N
    Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E and Alzheimer's disease.
    Troutwine BR; Hamid L; Lysaker CR; Strope TA; Wilkins HM
    Acta Pharm Sin B; 2022 Feb; 12(2):496-510. PubMed ID: 35256931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer's Disease Pathogenesis.
    Borràs C; Mercer A; Sirisi S; Alcolea D; Escolà-Gil JC; Blanco-Vaca F; Tondo M
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The link between cholesterol and Alzheimer's disease.
    Sjögren M; Blennow K
    World J Biol Psychiatry; 2005; 6(2):85-97. PubMed ID: 16156481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOE and Alzheimer's Disease: From Lipid Transport to Physiopathology and Therapeutics.
    Husain MA; Laurent B; Plourde M
    Front Neurosci; 2021; 15():630502. PubMed ID: 33679311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E gene and Alzheimer's disease: is tau the link?
    Lovestone S; Anderton B; Betts J; Dayanandan R; Gibb G; Ljungberg C; Pearce J
    Biochem Soc Symp; 2001; (67):111-20. PubMed ID: 11447827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E receptors: linking brain development and Alzheimer's disease.
    Herz J; Beffert U
    Nat Rev Neurosci; 2000 Oct; 1(1):51-8. PubMed ID: 11252768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of aluminum trichloride on expression of phosphorylated tau and Aβ in SH-SY5Y cells].
    Lu XT; Wang H; Jia ZJ; Li QY; Niu Q
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 May; 35(5):359-361. PubMed ID: 28780795
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.
    Barron AM; Verdile G; Martins RN
    Endocrine; 2006 Apr; 29(2):257-69. PubMed ID: 16785601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease.
    Sato N; Morishita R
    Front Aging Neurosci; 2015; 7():199. PubMed ID: 26557086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.